- Forums
- ASX - By Stock
- NXL
- Ann: FY23 Preliminary Results Update
Ann: FY23 Preliminary Results Update, page-71
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.38 |
Change
-0.120(3.43%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.710M | 790.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 776 | $3.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.21 | 187 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 8778 | 3.390 |
7 | 4670 | 3.380 |
12 | 29761 | 3.370 |
10 | 47500 | 3.360 |
5 | 4815 | 3.350 |
Price($) | Vol. | No. |
---|---|---|
3.400 | 1861 | 6 |
3.410 | 20501 | 7 |
3.420 | 20546 | 10 |
3.430 | 6140 | 5 |
3.440 | 3250 | 2 |
Last trade - 15.59pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online